Cite
HARVARD Citation
Wester, R. et al. (2022). Pomalidomide in Patients With Relapsed and/or Refractory Multiple Myeloma: A Prospective Study Within the Nationwide Netherlands Cancer Registry. HemaSphere. 6 (2), pp. e683-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wester, R. et al. (2022). Pomalidomide in Patients With Relapsed and/or Refractory Multiple Myeloma: A Prospective Study Within the Nationwide Netherlands Cancer Registry. HemaSphere. 6 (2), pp. e683-. [Online].